Table 3.
Bacterial strain | Antimicrobial effect | Reference |
---|---|---|
Lactobacillus brevis 925A | Brevicin 925A has antimicrobial effect against Listeria monocytogenes and Streptococcus mutans | [77] |
Lactobacillus fermentum CS57 | In vitro antimicrobial activity against Streptococcus agalactiae and Candida albicans (vaginal ecosystem) Bacteriocin-like substance as antimicrobial molecule |
[67] |
Lactobacillus johnsonii NCC 533 (previously Lactobacillus acidophilus LA1) |
Spent culture supernatant from LA1 contains antimicrobial components that reduce the amount on Salmonella typhimurium in vivo (murine models of infections) and in vitro (Caco-2 model) | [6, 44] |
Antimicrobial activity by LjNCC533 associated to lactic acid and hydrogen peroxide production | [2] | |
Lactobacillus salivarius UCC118 and DPC6488 | Secretion of the Abp118 bacteriocin with antimicrobial activity against the Listeria monocytogenes in vivo model (rodents) Lactobacillus salivarius DPC6488: secretion of two bacteriocins (salivaricin L and T) with analogies with Abp118 (see reference for details) |
[19, 24] |
Lactobacillus plantarum G1 and G3 | Bacteriocin-like activity identified and characterized with antimicrobial properties (for specificity see reference) Potential probiotics: high vitality in the GIT, no toxicity (safety), improved lipid metabolism, and hepatic function |
[82] |